| scholarly article | Q13442814 |
| P50 | author | Jean-Luc Balligand | Q57005516 |
| P2093 | author name string | P Sonveaux | |
| O Feron | |||
| C Dessy | |||
| S Moniotte | |||
| A Brouet | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 866-873 | |
| P577 | publication date | 2001-11-01 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins | |
| P478 | volume | 89 |
| Q45854741 | 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (fluvastatin) decreases inflammatory angiogenesis in mice |
| Q37680946 | A clinical review of statins and cancer: helpful or harmful? |
| Q41952585 | Absence of dystrophin in mice reduces NO-dependent vascular function and vascular density: total recovery after a treatment with the aminoglycoside gentamicin. |
| Q44846597 | Acute activation and phosphorylation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors |
| Q34515584 | Adventures in vascular biology: a tale of two mediators |
| Q34429244 | Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapy |
| Q34984769 | Anticancer and antiangiogenic activity of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer therapy. |
| Q41833012 | Atorvastatin affects several angiogenic mediators in human endothelial cells |
| Q46467576 | Atorvastatin induces associated reductions in platelet P-selectin, oxidized low-density lipoprotein, and interleukin-6 in patients with coronary artery diseases |
| Q34669052 | Atorvastatin prevents Plasmodium falciparum cytoadherence and endothelial damage |
| Q42931739 | Atorvastatin upregulates nitric oxide synthases with Rho-kinase inhibition and Akt activation in the kidney of spontaneously hypertensive rats |
| Q44307951 | Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway |
| Q44443108 | Attenuation of chronic hypoxic pulmonary hypertension by simvastatin |
| Q35084723 | Beyond lipid-lowering: effects of statins on endothelial nitric oxide |
| Q38374290 | Caveolae as a target to quench autoinduction of the metastatic phenotype in lung cancer |
| Q37886183 | Caveolae, caveolin, and cavins: potential targets for the treatment of cardiac disease |
| Q40656012 | Caveolin interacts with the angiotensin II type 1 receptor during exocytic transport but not at the plasma membrane |
| Q38923177 | Caveolin-1 mediates inflammatory breast cancer cell invasion via the Akt1 pathway and RhoC GTPase |
| Q36729403 | Caveolin-1 regulates cancer cell metabolism via scavenging Nrf2 and suppressing MnSOD-driven glycolysis |
| Q60684988 | Changes in Hsp90 expression determine the effects of cyclosporine A on the NO pathway in rat myocardium |
| Q57364640 | Chapter 10 Caveolae and Caveolins in the Vascular System: Functional Roles in Endothelia, Macrophages, and Smooth Muscle Cells |
| Q57364632 | Chapter 5 The Caveolin Interaction with Endothelial Nitric Oxide Synthase (eNOS) |
| Q24197803 | Cholesterol-reducing agents for aneurysmal subarachnoid haemorrhage |
| Q24241797 | Cholesterol-reducing agents for aneurysmal subarachnoid haemorrhage |
| Q37123792 | Clinical implications of caveolins in malignancy and their potential as therapeutic targets |
| Q37408161 | Differential effects of nitric oxide synthesis on pulmonary vascular function during lung ischemia-reperfusion injury |
| Q35804090 | Direct in vivo evidence of a vascular statin: a single dose of cerivastatin rapidly increases vascular endothelial responsiveness in healthy normocholesterolaemic subjects |
| Q36747218 | Disruption of endothelial cell mitochondrial bioenergetics in lambs with increased pulmonary blood flow |
| Q46792342 | Dissociation of endothelial nitric oxide synthase phosphorylation and activity in uterine artery endothelial cells |
| Q34662351 | Docosahexaenoic acid improves the nitroso-redox balance and reduces VEGF-mediated angiogenic signaling in microvascular endothelial cells |
| Q46919466 | Effect of Cissampelos capensis rhizome extract on human spermatozoa in vitro. |
| Q44384630 | Effect of atorvastatin on endothelium-dependent vasodilation in patients with coronary artery disease |
| Q53059087 | Effect of atorvastatin on the angiogenic responsiveness of coronary endothelial cells in normal and streptozotocin (STZ) induced diabetic rats. |
| Q34407389 | Effect of nuclear actin on endothelial nitric oxide synthase expression |
| Q46512858 | Effects of rapamycin on the arterial inflammatory response in atherosclerotic plaques in Apo-E knockout mice. |
| Q36242351 | Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol |
| Q43111572 | Effects of statins on nitric oxide/cGMP signaling in human umbilical vein endothelial cells |
| Q36042713 | Emerging role of PKA/eNOS pathway in therapeutic angiogenesis for ischaemic tissue diseases |
| Q42038406 | Endothelial caveolae and caveolin-1 as key regulators of atherosclerosis |
| Q27009407 | Endothelial caveolar subcellular domain regulation of endothelial nitric oxide synthase |
| Q36992714 | Endothelial nitric oxide (NO) and its pathophysiologic regulation |
| Q35574173 | Endothelial nitric oxide synthase and endothelial dysfunction. |
| Q86403863 | Fibrates protect against vascular endothelial dysfunction induced by paclitaxel and carboplatin chemotherapy for cancer patients: a pilot study |
| Q33985983 | Fluoxetine induces vasodilatation of cerebral arterioles by co-modulating NO/muscarinic signalling |
| Q63384563 | Geldanamycin treatment reduces neovascularization in a mouse model of retinopathy of prematurity |
| Q36187025 | Heat-shock protein 90 inhibitors in antineoplastic therapy: is it all wrapped up? |
| Q36396658 | Human, vector and parasite Hsp90 proteins: A comparative bioinformatics analysis. |
| Q46200912 | Impact of cyclic hypoxia on HIF-1alpha regulation in endothelial cells--new insights for anti-tumor treatments |
| Q41880179 | Improvement of age-related endothelial dysfunction by simvastatin: effect on NO and COX pathways |
| Q35930087 | Inhibition of heat shock protein (molecular weight 90 kDa) attenuates proinflammatory cytokines and prevents lipopolysaccharide-induced liver injury in mice. |
| Q36596684 | Is caveolin-1 a viable therapeutic target to reduce cancer metastasis? |
| Q36805328 | Life history of eNOS: partners and pathways |
| Q35026501 | Microcirculation as a target for the anti-inflammatory properties of statins. |
| Q37138906 | Modulation of PKCdelta signaling alters the shear stress-mediated increases in endothelial nitric oxide synthase transcription: role of STAT3. |
| Q35688796 | Molecular chaperones in Parkinson's disease--present and future |
| Q46398198 | Molecular cloning of ovine endothelial nitric oxide synthase and expression in COS-7 cells |
| Q50848558 | Molecular modeling and simulation of the human eNOS reductase domain, an enzyme involved in the release of vascular nitric oxide. |
| Q38423887 | Myocardial tissue caveolae |
| Q35603936 | NO and angiogenesis |
| Q44375078 | Nebivolol-induced vasodilation of renal afferent arterioles involves β3-adrenergic receptor and nitric oxide synthase activation |
| Q43244752 | Neither K+ channels nor PI3K/Akt mediates the vasodilative effect of nebivolol on different types of rat arteries |
| Q34513279 | Netrin-1 induces angiogenesis via a DCC-dependent ERK1/2-eNOS feed-forward mechanism |
| Q33200943 | Nitric oxide modulates caveolin-1 and matrix metalloproteinase-9 expression and distribution at the endothelial cell/tumor cell interface |
| Q36052567 | Nitropravastatin stimulates reparative neovascularisation and improves recovery from limb Ischaemia in type-1 diabetic mice |
| Q35821260 | Novel nitric oxide signaling mechanisms regulate the erectile response |
| Q43157591 | Peptide-stimulated angiogenesis: Role of lung endothelial caveolar signaling and nitric oxide |
| Q91679389 | Pharmacogenetic Implications of eNOS Polymorphisms (Glu298Asp, T786C, 4b/4a) in Cardiovascular Drug Therapy |
| Q24647863 | Pleiotropic effects of statins |
| Q35581165 | Post-translational modifications of Hsp90 and their contributions to chaperone regulation |
| Q46743802 | Pretreatment with high-dose statin, but not low-dose statin, ezetimibe, or the combination of low-dose statin and ezetimibe, limits infarct size in the rat. |
| Q36440894 | Recent advances in understanding endothelial dysfunction in atherosclerosis |
| Q46813803 | Regenerative response in the pig liver remnant varies with the degree of resection and rise in portal pressure |
| Q40048813 | Regulation of 3-phosphoinositide-dependent protein kinase-1 (PDK1) by Src involves tyrosine phosphorylation of PDK1 and Src homology 2 domain binding |
| Q30612023 | Regulation of NADPH-dependent Nitric Oxide and reactive oxygen species signalling in endothelial and melanoma cells by a photoactive NADPH analogue |
| Q38158103 | Regulation of endothelial nitric oxide synthase activity by protein-protein interaction. |
| Q27026289 | Role of caveolin-1 and caveolae signaling in endotoxemia and sepsis |
| Q52369978 | Role of mTORC1 Controlling Proteostasis after Brain Ischemia. |
| Q44492204 | Simvastatin promotes cardiac microvascular endothelial cells proliferation, migration and survival by phosphorylation of p70 S6K and FoxO3a |
| Q79412239 | Single administration of cerivastatin, an HMG-CoA reductase inhibitor, improves the coronary flow velocity reserve: a transthoracic Doppler echocardiography study |
| Q51332321 | Sphingosine 1-phosphate protects primary human keratinocytes from apoptosis via nitric oxide formation through the receptor subtype S1P₃. |
| Q36095735 | Src-mediated phosphorylation of Hsp90 in response to vascular endothelial growth factor (VEGF) is required for VEGF receptor-2 signaling to endothelial NO synthase. |
| Q35587185 | Statin therapy and angiogenesis |
| Q81623503 | Statins and stroke |
| Q36571458 | Statins and the endothelium |
| Q36088110 | Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials. |
| Q26853120 | Statins as regulators of redox state in the vascular endothelium: beyond lipid lowering |
| Q42452556 | Statins differentially regulate vascular endothelial growth factor synthesis in endothelial and vascular smooth muscle cells |
| Q37276056 | Statins in endothelial signaling and activation |
| Q30446668 | Statins in liver disease: a molehill, an iceberg, or neither? |
| Q35821728 | Targeting Histone Deacetylases in Diseases: Where Are We? |
| Q56888724 | Targeting the MMP-14/MMP-2/integrin αβ axis with multispecific N-TIMP2-based antagonists for cancer therapy |
| Q34200930 | Targeting the lactate transporter MCT1 in endothelial cells inhibits lactate-induced HIF-1 activation and tumor angiogenesis. |
| Q46182070 | Temporal gene expression analysis of human coronary artery endothelial cells treated with Simvastatin. |
| Q28293417 | The CD47-binding peptide of thrombospondin-1 induces defenestration of liver sinusoidal endothelial cells |
| Q28083829 | The critical role of Akt in cardiovascular function |
| Q35595431 | The many roles of statins in ischemic stroke |
| Q33350185 | The pleiotropic effects of simvastatin on retinal microvascular endothelium has important implications for ischaemic retinopathies |
| Q37719311 | The regulation of endothelial nitric oxide synthase by caveolin: a paradigm validated in vivo and shared by the 'endothelium-derived hyperpolarizing factor'. |
| Q51424623 | The role of heat shock proteins and co-chaperones in heart failure. |
| Q38168762 | The spectrum of statin therapy in cancer patients: is there a need for further investigation? |
| Q38928432 | Tipping off endothelial tubes: nitric oxide drives tip cells |
| Q46078255 | Valsartan regulates the interaction of angiotensin II type 1 receptor and endothelial nitric oxide synthase via Src/PI3K/Akt signalling |
| Q43002344 | Where is endothelial nitric oxide synthase more critical: plasma membrane or Golgi? |
| Q40516121 | alpha-thrombin rapidly induces tyrosine phosphorylation of a novel, 74-78-kDa stress response protein(s) in lung fibroblast cells. |
| Q91800751 | p53 plays a crucial role in endothelial dysfunction associated with hyperglycemia and ischemia |
Search more.